NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro
about
Functional selectivity of recombinant mammalian SWI/SNF subunitsInteraction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase IIHeterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control regionStimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylationInteraction of NF-E2 in the human beta-globin locus control region before chromatin remodelingRegulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cellsLoading of DNA-binding factors to an erythroid enhancer.p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.GAL4 directs nucleosome sliding induced by NURF.The beta-globin locus control region versus gene therapy vectors: a struggle for expression.Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locusThe world according to MafContext-dependent regulation of GATA-1 by friend of GATA-1.Beta-globin intergenic transcription and histone acetylation dependent on an enhancer.CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation.Important roles of reversible acetylation in the function of hematopoietic transcription factors.Nucleosome and transcription activator antagonism at human beta-globin locus control region DNase I hypersensitive sites.Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control regionp53 sumoylation: mechanistic insights from reconstitution studies.The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line.The role of transcriptional activator GATA-1 at human beta-globin HS2Nucleosome positioning and gene regulation: advances through genomics.Complete TCR-α gene locus control region activity in T cells derived in vitro from embryonic stem cellsMi2beta shows chromatin enzyme specificity by erasing a DNase I-hypersensitive site established by ACF.A novel role for nuclear factor-erythroid 2 in erythroid maturation by modulation of mitochondrial autophagy.Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genesStructure and function of active chromatin and DNase I hypersensitive sites.CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly.Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease.Enhancer activity of HS2 of the human beta-LCR is modulated by distance from the key nucleosomeStimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators.Xenopus TFIIIA gene transcription is dependent on cis-element positioning and chromatin structure.Multiple regions of p45 NF-E2 are required for beta-globin gene expression in erythroid cells.Protein-DNA interactions in the human beta-globin locus control region hypersensitive site-2 as revealed by four nitrogen mustards.Erythroid gene suppression by NF-kappa B.Transcriptional control of the human thromboxane synthase gene in vivo and in vitro.Distinction between AP1 and NF-E2 factor-binding at specific chromatin regions in mammalian cells.
P2860
Q24290358-2C541A17-D5E4-406F-BA2D-1E7942369360Q24313410-E671940D-873B-43B1-B894-1555DC990B1EQ24338101-7BEDAAEC-A066-4E01-8C49-02BA53DBD9D1Q28142527-54EAAB6E-5276-4105-9B4D-04392BC0CDC8Q28201249-272195CA-979F-4E4B-98A6-122802FE7A92Q29037128-42028C98-3E33-40BD-AAB3-4E657A8169B5Q33786937-33454A8B-9F66-4DFF-B728-8B3F754A20F6Q33887503-CB87C72B-A788-4BA3-9069-FDF31AD23181Q33960162-426FC817-184A-4732-AF87-DFCB5EAE4371Q34086198-8214149A-4E58-46AA-A3B0-03AC9F0CFE11Q34135439-19B1E032-AEC8-4594-9508-01FD619E5FC6Q34150764-20B39AE1-0D93-4ED8-B74E-579E4892DE4DQ34632392-32D8AC19-6C9E-44EA-AE53-37EDEAB6E438Q35733779-781C207A-8DF5-4CA5-80F9-BD997194A951Q35856822-EFF6181A-D50F-4196-ACD7-139F413347C7Q35901820-E3DFED5D-5759-4EF6-87A0-DC3EACB6FE46Q36077401-020CDD34-4012-4005-8E55-A23565DA91E8Q36082870-A3407DB5-B9B2-4D54-A104-F9B8F0578D30Q36379368-1C1CD17B-FEE0-4558-B733-FD6D343C8BF1Q36563365-CE7ED0D7-865F-4087-8704-9EE5CCA9F2C7Q36567469-574FE30D-4627-4203-8025-4192DFB62900Q36580348-E2890C2F-7E09-4AB7-8318-64C4B3A21C2BQ36824044-95550942-A77A-4BB5-B78F-7A19B89AC586Q36883122-4D99DB02-1822-465E-ACC6-37C02FB79987Q37127489-8A51D825-19C5-4998-8A8B-9F570D2991A2Q37134371-CD460B20-FDE3-42A9-BAE6-CBEB581FC8F7Q37331214-AB62B8E6-F895-45B2-BB49-79EFBDECD6A1Q37374740-15DF7818-1DF2-4C12-8527-6BBFBF8C6FFFQ37866375-27CA56AF-C235-4C1D-A89A-06C2516D8F0BQ38297621-8925D9C3-D640-4153-93AA-8626FF3AA43DQ38302380-47AFEE8F-B802-44EC-A88A-6072F4D4F350Q38900001-82C818E3-66F5-4527-A30B-3911A7FB886FQ39097055-AB9B25ED-0283-4C7B-A37A-7CD6E2B791E7Q39457338-ECEC1CF5-C1CB-4571-9925-A3BB481982A9Q39575123-0CC08448-17F4-44FB-8BD6-A82EEDBA9A65Q39720357-E60474B3-B3FF-442A-A53F-2557A02D3F76Q39720835-FB84E39E-77B1-4CE4-9C19-14B278051203Q40663278-67FFFC88-5C8E-46B6-BB9B-10F3794A51EBQ40737861-CEA9669B-358E-4EF0-BA44-CA68F760A84DQ41692278-84C6D134-A8DE-42B4-B2BD-5E7DD1D54A44
P2860
NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro
description
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1996
@ast
im Oktober 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1996/10/01)
@sk
vědecký článek publikovaný v roce 1996
@cs
wetenschappelijk artikel (gepubliceerd op 1996/10/01)
@nl
наукова стаття, опублікована в жовтні 1996
@uk
مقالة علمية (نشرت في أكتوبر 1996)
@ar
name
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@ast
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@en
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@nl
type
label
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@ast
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@en
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@nl
prefLabel
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@ast
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@en
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@nl
P2860
P356
P1476
NF-E2 disrupts chromatin struc ...... hypersensitive site 2 in vitro
@en
P2093
B. M. Emerson
J. A. Armstrong
P2860
P304
P356
10.1128/MCB.16.10.5634
P407
P577
1996-10-01T00:00:00Z